Transduced Tat-Annexin protein suppresses inflammationassociated gene expression in lipopolysaccharide (LPS)-stimulated Raw 264.7 cells

키워드

참고문헌 (39)

1. Bertolini, A, "Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks", Curr. Med. Chem, 9, pp.1033~1043 (2002)
2. Korhonen, R, "Nitric oxide production and signaling in inflammation", Curr. Drug Targets Inflamm. Allergy, 4, pp.471~479 (2005)
3. Libby, P, "Inflammation and atherosclerosis", Circulation, 105, pp.1135~1143 (2000)
4. Tilley, S. L, "Mixed message gene: modulation of inflammation and immune responses by prostaglandins and thromboxanes", J. Clin. Invest, 107, pp.191~195 (2001)
5. Carey, M. A, "Cyclooxygenase enzymes in allergic inflammation and asthma. Prostaglandins Leukot", Essent. Fatty Acids, 69, pp.157~162 (2003)
6. Vancheri, C, "The lung as a privileged site for the beneficial actions of PEG2", Trends Immunol, 25, pp.40~46 (2004)
7. Lawrence, T, "Possible new role for NF-kB in the resolution of inflammation", Nat. Med, 7, pp.1291~1297 (2001)
8. Rietschel, E. T, "Bacterial endotoxin: molecular relationships and structure to activity and function", FASEB J, 8, pp.217~225 (1994)
9. Mararov,S.S, "NF-kB as a therapeutic target in chronic inflammation: recent advances", Mol. Med. Today, 6, pp.441~448 (2000)
10. Renard, P, "The proinflammatory transcription factor NF-kB: a potential target for novel therapeutical strategies", Cell Biol. Toxicol, 15, pp.341~344 (1999)
11. Babbin, B, "Annexin A1 regulates intestinal mucosal injury, inflammation, and repair", J. Immunol, 181, pp.5035~5044 (2008)
12. Kamal, A. M, "An overview of the effects of annexin 1 on cells involved in the inflammatory process", Mem. Inst. Oswaldo Cruz. Rio de Janeiro, 100(suppl 1), pp.39~48 (2005)
13. Perretti, M, "Annexin A1 and glucocorticoids as effectors of the resolution of inflammation", Nat. Rew. Immunol, 9, pp.62~70 (2009)
14. Wadia, J, "Protein transduction technology", Curr. Opin. Biotechnol, 13, pp.52~56 (2002)
15. Ahn, E. H, "Transduced PEP-1-ribosomal protein S3 (rpS3) ameliorates 12-O-tetradecanoylphorbol-13-acetate-induced inflammation in mice", Toxicology, 276, pp.192~197 (2010)
16. An, J. J, "Transduced human PEP-1-heat shock protein 27 efficiently protects against brain ischemic insult", FEBS JOURNAL, 275, pp.1296~1308 (2008), BLACKWELL PUBLISHING
17. Choi, H. S, "PEP-1-SOD fusion protein efficiently protects against paraquat-induced dopaminergic neuron damage in a Parkinson disease mouse model", Free Radic. Biol, 41, pp.1058~1068 (2006)
18. Eum, W. S, "HIV-1 Tat-mediated protein transduction of Cu,Zn-superoxide dismutase into pancreatic β cells in vitro and in vivo", Free Radical Biology and Medicine, 37(3), pp.339~349 (2004), Elsevier BV
19. Kim, D. W, "Transduced PEP-1-catalase fusion protein attenuates ischemic neuronal damage", Free Radic. Biol. Med, 47, pp.941~952 (2009)
20. Sun Hwa Lee, "Enhancement of HIV-1 Tat fusion protein transduction efficiency by bog blueberry anthocyanins", BMB reports, 43(8), pp.561~566 (2010), 생화학분자생물학회
21. Egleton, R. D, "Bioavailability and transport of peptides and peptide drugs into the brain", Peptides, 18, pp.1431~1439 (1997)
22. Dietz, G. P, "Cell-penetrating peptide technology to delivery chaperones and associated factors in diseases and basic research", Curr. Pharm. Biotechnol, 11, pp.167~174 (2010)
23. Adams, D. O, "The cell biology of macrophage activation", Annu. Rev. Immunol, 2, pp.283~318 (1984)
24. Morrison, D. C, "Endotoxins and disease mechanisms", Annu. Rev. Med, 38, pp.417~432 (1987)
25. Hannon, R, "Aberrant inflammation and resistance to glucocorticoids in annexin1-", - mouse, 2003, pp.17, 253~255
26. FASEB J, "The role of lipocortin-1 in dexamethasone-induced suppression of PGE2 and TNF-α release from human peripheral blood mononuclear cells", Br. J. Pharmacol, 117, pp.1449~1456 (1996)
27. D’Acquisto, F, "Inhibition of inducible nitric oxide synthase gene expression by glucocorticoid-induced proteins in lipopolysaccharide- stimulated J774 cells", Eur. J. Pharmacol, 339, pp.87~95 (1997)
28. Ferlazzo, V, "Anti-inflammatory effects of annexin-1: stimulation of IL-10 release and inhibition of nitric oxide synthase", Int. Immunopharmacol, 3, pp.1363~1369 (2003)
29. Pieretti, S, "Stimulus-dependent specificity for annexin 1 inhibtion of the inflammatory nociceptive response: the involvement of the receptor for formylated peptides", Pain, 109, pp.52~63 (2004)
30. Porro, C. A, "Spatial and temporal aspects of spinal cord and brainstem activation in the formalin pain model", Prog. Neurobiol, 41, pp.565~607 (1993)
31. Perretti, M, "Endogenous mediators that inhibit the leukocyote-endothelium interaction", Trends Pharmacol. Sci, 18, pp.418~425 (1997)
32. Cirino, G, "Anti-inflammatory actions of an N-terminal peptide from human lipocortin 1", Br. J. Pharmacol, 108, pp.573~574 (1993)
33. Gayathri, B, "Pure compound from Boswellia serrata extract exhibits anti-inflammatory property in human PBMCs and mouse macrophages through inhibition of TNFα, IL-1β, NO and MAP kinases", Int. Immunopharmacol, 7, pp.473~482 (2007)
34. Medicherla, S, "Topical alpha-selective p38 MAP kinase inhibition reduces acute skin inflammation in guinea pig", J. Inflamm. Res, 3, pp.9~16 (2010)
35. Lebwohl, M, "A clinician’s paradigm in the treatment of psoriasis", J. Am. Acad. Dermatol, 53, pp.59~69 (2005)
36. Barnes, P. J, "Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases", N. Engl. J. Med, 336, pp.1066~1071 (1997)
37. Yun, K. J, "Inhibition of LPS-induced NO and PGE2 production by asiatic acid via NF-kB inactivation in Raw 264.7 macrophages: Possible involvement of the IKK and MAPK pathways", Int. Immunopharmacol, 8, pp.431~441 (2008)
38. Kwon, H. Y, "Transduction of Cu,Zn-superoxide dismutase mediated by an HIV-1 Tat protein basic domain into mammalian cells", FEBS Lett, 485, pp.163~167 (2000)
39. Bradford, M. A, "A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding", Anal. Biochem, 72, pp.248~254 (1976)

관련 논문AI추천